CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

INOVIO Announces Pricing of $20.0 Million Public Offering

Neutral
AI Analysis

Summary

INOVIO Pharmaceuticals announced pricing of a $20.0 million public offering. The company is a biotechnology firm focused on developing DNA medicines for HPV-related diseases, cancer, and infectious diseases.

Importance:5/10
Sentiment:
0.00
DNA medicinespublic offeringcapital raise
Related Companies

Read the original article

Published by PR Newswire Pharma on July 30, 2026 12:53 AM

Read Original